| __timestamp | ACADIA Pharmaceuticals Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 9216000000 |
| Thursday, January 1, 2015 | 76369000 | 8296000000 |
| Friday, January 1, 2016 | 4406000 | 10044000000 |
| Sunday, January 1, 2017 | 13060000 | 11560000000 |
| Monday, January 1, 2018 | 18330000 | 10558000000 |
| Tuesday, January 1, 2019 | 19598000 | 9351000000 |
| Wednesday, January 1, 2020 | 20550000 | 8933000000 |
| Friday, January 1, 2021 | 19141000 | 8284000000 |
| Saturday, January 1, 2022 | 10166000 | 7952000000 |
| Sunday, January 1, 2023 | 45731000 | 8200000000 |
| Monday, January 1, 2024 | 8480000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. Over the past decade, Teva Pharmaceutical Industries Limited and ACADIA Pharmaceuticals Inc. have shown contrasting trends in their cost of revenue. Teva, a global leader, saw a 14% decrease from 2014 to 2023, reflecting strategic cost management amidst market challenges. In contrast, ACADIA, a niche player, experienced a 24% drop in costs, with a notable spike in 2023, indicating potential shifts in operational strategies or market conditions. These trends highlight the diverse approaches within the industry, where larger firms focus on efficiency, while smaller companies may face volatility. As the pharmaceutical landscape continues to change, monitoring these financial metrics offers valuable insights into company strategies and market positioning.
Cost of Revenue Comparison: Merck & Co., Inc. vs ACADIA Pharmaceuticals Inc.
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Veracyte, Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Biogen Inc. and ACADIA Pharmaceuticals Inc.
Cost of Revenue Trends: Xenon Pharmaceuticals Inc. vs ACADIA Pharmaceuticals Inc.
Cost of Revenue: Key Insights for ACADIA Pharmaceuticals Inc. and Supernus Pharmaceuticals, Inc.
Cost of Revenue Comparison: ACADIA Pharmaceuticals Inc. vs Wave Life Sciences Ltd.
Cost of Revenue Comparison: ACADIA Pharmaceuticals Inc. vs Ligand Pharmaceuticals Incorporated
Comparing Cost of Revenue Efficiency: ACADIA Pharmaceuticals Inc. vs MiMedx Group, Inc.